期刊文献+

布地奈德鼻喷剂治疗过敏性鼻炎患者的价值分析 被引量:2

Value of Budesonide Nasal Spray in the Treatment of Allergic Rhinitis
下载PDF
导出
摘要 目的:分析布地奈德鼻喷剂治疗过敏性鼻炎患者的应用价值。方法:选取本院收治的过敏性鼻炎患者60例分为两组各30例,对照组采用氯雷他定治疗,观察组在此基础上采用布地奈德鼻喷剂治疗,比较两组的治疗效果,统计不良反应发生情况,记录两组治疗前后的Th1/Th2特征性细胞因子水平。结果:观察组治疗有效率为(93.33%)高于对照组的(73.33%),差异有统计学意义(P<0.05);两组不良反应发生率比较,差异无统计学意义(P>0.05);治疗前两组的IL-4和IFN-γ水平比较,差异无统计学意义(P>0.05);治疗后观察组γ-干扰素(IFN-γ)高于对照组,白细胞介素-4(IL-4)低于对照组,差异有统计学意义(P<0.05)。结论:布地奈德鼻喷剂治疗过敏性鼻炎能够有效减轻患者临床症状,提升疗效,调节细胞因子水平,安全性良好。 Objective: To analyze the clinical value of budesonide nasal spray in the treatment of allergic rhinitis. Methods: 60 patients with allergic rhinitis were divided into two groups of 30 cases each. The control group was treated with loratadine. The observation group was treated with budesonide nasal spray on this basis. The treatment effects of the two groups were compared. Adverse reactions occurred. Th1/Th2 characteristic cytokine levels before and after treatment were recorded. Results: The effective rate of treatment in the observation group was(93.33%) higher than that in the control group(73.33%), and the difference was statistically significant(P<0.05). There was no significant difference in the incidence of adverse reactions between the two groups(P>0.05);Before treatment, there was no significant difference in the levels of IL-4 and IFN-γ between the two groups of patients(P>0.05);after treatment, the IFN-γ in the observation group was higher than that in the observation group. In the control group, the IL-4 in the observation group was lower than that in the control group, and the difference was statistically significant(P<0.05). Conclusion: Budesonide nasal spray can effectively alleviate the clinical symptoms of allergic rhinitis, improve the curative effect, regulate the level of cytokines, and has good safety.
作者 曾海波 董科 付丽艳 ZENG Hai-bo;DONG Ke;FU Li-yan(Dexing People’s Hospital,Shangrao Jiangxi 334200,China)
出处 《药品评价》 CAS 2019年第18期77-78,共2页 Drug Evaluation
关键词 布地奈德鼻喷剂 过敏性鼻炎 安全性 细胞因子 Budesonide Nasal Spray Allergic Rhinitis Safety Cytokines
  • 相关文献

二级参考文献46

  • 1顾之燕,董震.变应性鼻炎的诊治原则和推荐方案(2004年,兰州)[J].中华耳鼻咽喉头颈外科杂志,2005,40(3):166-167. 被引量:1693
  • 2宋理君,虞积仁.T细胞亚群分布的测定及其临床意义[J].国外医学(临床生物化学与检验学分册),1989,10(4):1-3.12. 被引量:18
  • 3Lee CH, Jang JH, Lee HJ, et al. Clinical characteristics of aller- gic rhinitis according to allergic rhinitis and its impact on asthma guidelines [ J ]. Clin Exp Otorhinolaryngo|, 2008,1 (4) : 196 -200.
  • 4中华耳鼻喉科头颈外科杂志编辑委员会,中华医学会耳鼻喉科分会.过敏性鼻炎的治疗原则和推荐方案(2004年,兰州)[J].中华耳鼻喉科头颈外科杂志,2005,40(3):166-167.
  • 5Schroeder JT, Schleimer RP, Lichtenstein LM, et al. Inhibition of cytokine generation and mediator release by human basophils trea- ted with desloratadine [ J ]. Clin Exp Allergy, 2001,31 (9) : 1369-1377.
  • 6Roumestan C, Henriquel C ,Gougat C, et al. HistamineH1 receptor antagonists inhibit nucle AR factor kappa B and activator protein 1 activitiesvia H1 receptor dependent and independent mechanisms [J]. Clin Exp Allergy,2008,38(6) :947-956.
  • 7Zhang L, Han D, Huang D et al. Prevalence of self-reported allergic rhinitis in eleven major cities in China [ J ] . Int Arch Allergy Immunol,2009,149( 1 ) :47-57.
  • 8Baars EW , Savelkoul HF. Citrus/Cydonia eomp. ean restore the immunological balance in seasonal allergic rhinitis related immunological paramete in vitro[J]. Mediators lnflamm,2008, 20 ( 3 ) :496-497.
  • 9Kemeny DM, Vyas B, Vukmanovic-Stejie M, et al. CD8 T Cell subsets and chronic obstructive pulmonary disease [ J ]. Am J Respir Crit Care Med,1999,160(5 Pt 2) :33-37.
  • 10Karlsson MR, Rugtveit J, Brandtzaeg P. Allergen-responsive CD4+ CD25+regulatory T cells in children who have out grown cow' smilk allergy[J]. Exp Med,2004,199(12) :1679-1688.

共引文献280

同被引文献33

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部